Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sipai Health Technology Co has a Cash Ratio of 0.90. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.
The historical rank and industry rank for Sipai Health Technology Co's Cash Ratio or its related term are showing as below:
FRA:AX1'
s Cash Ratio Range Over the Past 10 Years
Min: 0.89 Med: 1.45 Max: 2.73
Current: 0.9
During the past 7 years, Sipai Health Technology Co's highest Cash Ratio was 2.73. The lowest was 0.89. And the median was 1.45.
FRA:AX1's Cash Ratio is ranked better than 88.03% of 117
companies
in the Medical Distribution industry
Industry Median: 0.2
vs FRA:AX1: 0.90
Sipai Health Technology Co (FRA:AX1) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Sipai Health Technology Co Cash Ratio Related Terms
Sipai Health Technology Co Cash Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Sipai Health Technology Co's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sipai Health Technology Co Cash Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sipai Health Technology Co's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Sipai Health Technology Co's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sipai Health Technology Co (FRA:AX1) has a Cash Ratio of 0.90 as of Dec. 2025. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Sipai Health Technology Co and its competitors. This is 38% below median its historical median of 1.45. Over the past decade, Sipai Health Technology Co's Cash Ratio has ranged from 0.89 to 2.73. According to the industry distribution chart, Sipai Health Technology Co ranks #14 out of 117 companies in the Medical Distribution industry, placing it in the top 12%.
Is Sipai Health Technology Co's Cash Ratio too high?
Sipai Health Technology Co's current Cash Ratio of 0.90 is 38% below median its 10-year median of 1.45. Over the past 10 years, this metric has ranged from a low of 0.89 to a high of 2.73. The Medical Distribution industry median Cash Ratio is 0.20. Sipai Health Technology Co's value of 0.90 is 350% above this industry median. Based on the distribution chart, Sipai Health Technology Co ranks #14 out of 117 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Sipai Health Technology Co has a GF Score™ of 64/100, reflecting its overall financial health beyond just this single metric.
How does Sipai Health Technology Co's Cash Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Sipai Health Technology Co ranks #14 out of 117 companies for Cash Ratio. This places Sipai Health Technology Co in the top 12% of its industry — outperforming the majority of peers. The industry median Cash Ratio is 0.20. Sipai Health Technology Co's value of 0.90 is 350% above this benchmark. Historically, Sipai Health Technology Co's own Cash Ratio has ranged from 0.89 to 2.73 over the past decade. While the company's 10-year median is 1.45 vs. the industry median of 0.20, Sipai Health Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Medical Distribution company?
The median Cash Ratio among Medical Distribution companies is 0.20, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sipai Health Technology Co's current Cash Ratio of 0.90 is 350% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Sipai Health Technology Co and its competitors. For the Medical Distribution industry, the median Cash Ratio is 0.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sipai Health Technology Co's current Cash Ratio is 0.90, which is 38% below median its own 10-year median of 1.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sipai Health Technology Co stock overvalued right now?
Sipai Health Technology Co (FRA:AX1) has a current Cash Ratio of 0.90. The stock's GF Value™ is €0.22, compared to a current price of €0.14 — trading 35.5% below its estimated fair value. The current Cash Ratio is 0.90, which is 38% below median its 10-year median of 1.45 and 350% above the Medical Distribution industry median of 0.20. Sipai Health Technology Co's overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Sipai Health Technology Co (FRA:AX1), the current Cash Ratio is 0.90 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sipai Health Technology Co (FRA:AX1) Overvalued in 2026?
Based on GuruFocus' analysis, Sipai Health Technology Co stock appears to be undervalued.
The current stock price of €0.14 is trading 35.5% below its estimated GF Value™ of €0.22.
Key valuation signals for FRA:AX1:
Cash Ratio: 0.90 (38% below median its 10-year median of 1.45)
GF Value™: €0.22 vs. price of €0.14 (35.5% below fair value)
Industry Position: 350% above the Medical Distribution median (#14 of 117)
No single metric tells the full story. See the FRA:AX1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sipai Health Technology Co Ltd is a medical technology and health management company in China. The company has three reportable operating segments: Specialty Pharmacy Business - engaged in the operation and distribution of specialty pharmacy stores and pharmaceutical products; Physician Research Assistance Business - offering pharmaceutical companies and other clinical trial institutions site management organization services; Commercial Insurance Services Business - rendering insurance brokerage services to insurance companies and health management services to insurance carriers and enterprise clients. The company generates key revenue from the Specialty Pharmacy Business. Almost all of the company's revenues were derived from operations in the PRC.
64GF Score
Get the complete analysis for FRA:AX1
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:AX1 has been successfully added to your 
